title: Xpert MTB/RIF for tuberculosis testing: access and price in highly privatised health markets.
authors.affiliation: McGill International Tuberculosis Center, McGill University, Montreal, Canada.
authors.forename: Lekha
authors.initials: L
authors.lastname: Puri
authors.affiliation: McGill International Tuberculosis Center, McGill University, Montreal, Canada.
authors.forename: Collins
authors.initials: C
authors.lastname: Oghor
authors.affiliation: FIND, Geneva, Switzerland.
authors.forename: Claudia M
authors.initials: CM
authors.lastname: Denkinger
authors.affiliation: McGill International Tuberculosis Center, McGill University, Montreal, Canada; Department of Epidemiology and Biostatistics, 1020 Pine Avenue West, Montreal QC H3A 1A2, Canada. Electronic address: madhukar.pai@mcgill.ca.
authors.forename: Madhukar
authors.initials: M
authors.lastname: Pai
mesh_terms: D003132:Commerce; D004269:DNA, Bacterial / Q000032:analysis; D017048:Health Care Costs; D019981:Health Care Sector / Q000191:economics; D006297:Health Services Accessibility / Q000191:economics*; D006801:Humans; D025202:Molecular Diagnostic Techniques / Q000191:economics*; D009169:Mycobacterium tuberculosis / Q000235:genetics; D017149:Private Sector; D012293:Rifampin; D018088:Tuberculosis, Multidrug-Resistant / Q000175:diagnosis*
chemical_list: D004269:DNA, Bacterial; D012293:Rifampin